Abstract
Predicting drug-drug interactions (DDIs) has become a major concern in the drug research field because it helps explore the pharmacological function of drugs and enables the development of new therapeutic drugs. Existing prediction methods simply integrate multiple drug attributes or perform tasks on a biomedical knowledge graph (KG). Though effective, few methods can fully utilize multi-source drug data information. In this paper, a multi-view and multichannel attention deep learning (MMADL) model is proposed, which not only extracts rich drug features containing both drug attributes and drug-related entity information from multi-source databases, but also considers the consistency and complementarity of different drug feature representation learning approaches to improve the effectiveness and accuracy of DDI prediction. A single-layer perceptron encoder is applied to encode multi-source drug information to obtain multi-view drug representation vectors in the same linear space. Then, the multichannel attention mechanism is introduced to obtain the attention weight by adaptively learning the importance of drug features according to their contributions to DDI prediction. Further, the representation vectors of multi-view drug pairs with attention weights are used as inputs of the deep neural network to predict potential DDI. The accuracy and precision-recall curves of MMADL are 93.05 and 95.94, respectively. The results indicate that the proposed method outperforms other state-of-the-art methods.






Similar content being viewed by others
Data availability
The source codes and the data at https://github.com/Liyu-gx/MMADL.git.
References
Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the united states from 1999–2012. Obstet Gynecol Surv. 2015;314:1818–30.
Qato MD, Wilder J, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the united states, 2005 vs 2011. Pharmacoepidemiol Drug Saf. 2016;176:473–82.
Han K, Jeng EE, Hess GT, Morgens DW, Li A, Bassik MC. Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat Biotechnol. 2017;35:463–74.
Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Datadriven prediction of drug effects and interactions. Sci Transl Med. 2012;4:125ra31.
Pazdernik T. Lippincott’s illustrated reviews: pharmacology. Med Sci Sports Exerc. 2009;41:1531.
Prueksaritanont T, Chu X, Gibson C, Cui D, Yee KL, Ballard J, Cabalu T, Honchman J. Drug-drug interaction studies: regulatory guidance and an industry perspective. AAPS J. 2013;15:629–45.
Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, Mcnamee C. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41–58.
Jiang HJ, Huang YA, You ZH. Predicting drug-disease associations via using gaussian interaction profile and kernel-based autoencoder. Biomed Res Int. 2019;2019:1–1.
Li ZC, Huang QX, Chen X, Wang Y, Li JL, Xie Y, Dai D, Zou XY. Identification of drug-disease associations using information of molecular structures and clinical symptoms via deep convolutional neural network. Front Chem. 2020;7:924.
Yu Z, Huang F, Zhao X, Xiao W, Zhang W. Predicting drug-disease associations through layer attention graph convolutional network. Brief Bioinform. 2020;22:1–1.
Monteiro N, Ribeiro B, Arrais J. Drug-target interaction prediction: end-to-end deep learning approach. IEEE-ACM Trans Comput Biol Bioinform. 2020;18:2364–74.
Lian MJ, Wang XJ, Du WL. Integrated multi-similarity fusion and heterogeneous graph inference for drugtarget interaction prediction. Neurocomputing. 2022;500:1–2.
Xu L, Ru XQ, Song R. Application of machine learning for drug-target Interaction prediction. Front Genet. 2021;12: 680117.
Munir A, Elahi S, Masood N. Clustering based drug-drug interaction networks for possible repositioning of drugs against EGFR mutations: clustering based DDI networks for EGFR mutations. Comput Biol Chem. 2018;75:24–31.
Ryu JY, Kim HU, Lee SY. Deep learning improves prediction of drug-drug and drug-food interactions. Proc Natl Acad Sci U S A. 2018;115:E4304–11.
Deng YF, Yang Q, Xu XR, Liu SC, Zhang ZF, Zhu SF, Zhang W. META-DDIE: predicting drug-drug interaction events with few-shot learning. Brief Bioinform. 2022;23:1–8.
Vilar S, Uriarte E, Santana L. Similarity-based modeling in large-scale prediction of drug-drug interactions. PNat Protoc. 2014;9:2147–63.
Yan C, Duan G, Zhang Y, Wu FX, Wang J. Predicting drug-drug interactions based on integrated similarity and semi-supervised learning. IEEE-ACM Trans Comput Biol Bioinform. 2020;9:168–79.
Lee G, Park C, Ahn J. Novel deep learning model for more accurate prediction of drug-drug interaction effects. BMC Bioinformatics. 2019;20:415.
Zhang WA, Jing KC, Huang FB, Chen YC, Li BB, Li JB, Gong JA. Sflln: a sparse feature learning ensemble method with linear neighborhood regularization for predicting drug-drug interactions. Inf Sci. 2019;497:189–201.
Zhang YJ, Zheng W, Lin HF, Wang J, Yang ZH, Dumontier M. Drug-drug interaction extraction via hierarchical RNNs on sequence and shortest dependency paths. Bioinformatics. 2018;34:828–35.
Deng Y, Xu X, Qiu Y, Xia J, Liu S. Amultimodal deep learning framework for predicting drug-drug interaction events. Bioinformatics. 2020;36:4316–22.
Wang F, Lei XJ, Liao B, Wu FX. Predicting drug-drug interactions by graph convolutional network with multi-kernel. Brief Bioinform. 2021;23:1–11.
Nickel M, Murphy K, Tresp V, Gabrilovich E. A review of relational machine learning for knowledge graphs. Proc IEEE. 2016;104:11–33.
Tiddi I, Schlobach S. Knowledge graphs as tools for explainable machine learning: a survey. Artif Intell. 2022;302:103627.
Fokoue A, Sadoghi M, Hassanzadeh O, Ping Z. Predicting drug-drug interactions through large-scale similarity-based link prediction. In: Proceedings 13th ESWC Conference 774–789 (2016)
Trouillon T, Welbl J, Riedel S, Gaussier R, Bouchard G. Complex embeddings for simple link prediction. In: Proceedings 33rd ICML 2071–2080 (2016)
Karim MR, Cochez M, Jares JB, Uddin M, Beyan O, Decker S. Drug-drug interaction prediction based on knowledge graph embeddings and convolutional-LSTM network. In 10th ACM Conference BCB 113–123 (2019)
Lin X, Quan Z, Wang ZJ, Ma T, Zeng X. KGNN: knowledge graph neural network for drug-drug interaction prediction. In: Proceedings 29th IJCAI-PRICAI-20 2739–2745 (2020)
Niu ZY, Zhong GQ, Hui Y. A review on the attention mechanism of deep learning. Neurocomputing. 2021;452:48–62.
Chen X, Liu X, Wu J. Drug-drug interaction prediction with graph representation learning. In: IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 354–361 (2019)
Nyamabo, AK, Yu, H, Shi, JY. SSI-DDI: substructure-substructure interactions for drug-drug interaction prediction, Brief. Bioinform. 2021; 22:bbab133
Lu J, Yang W, Batra D, Parikh D. Hierarchical question-image coattention for visual question answering. In: Proceedings 34th AAAI Conference, 702–709 (2020)
Wang Y, Min Y, Chen X, Wu J. Multi-view graph contrastive representation learning for drug-drug interaction prediction. In: WWW ’21: The Web Conference 2021, 2921–2933 (2021)
Feng YY, Yu H, Feng YH, Shi JY. Directed graph attention networks for predicting asymmetric drug–drug interactions. Brief Bioinform. 2022;23:bbac151.
Su XR, Hu L, You ZH, Hu PW, Zhao BW. Attention-based knowledge graph representation learning for predicting drug-drug interactions. Brief Bioinform. 2022;23:bbac140.
Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Zhan C, Woolsey J. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668–72.
Ioannidis VN, Song X, Manchanda S, Li M, Pan X, Zheng D, Ning X, Zeng X, Karypis G (2020) DRKG-Drug Repurposing Knowledge Graph for Covid-19. https://github.com/gnn4dr/DRKG.
Wishart DS, Feunang YD, Guo AC, Lo E, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z. Drugbank 5.0: a major update to the drugbank database for 2018. Nucleic Acids Res. 2018;46:1074-D1082.
Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010;38:D355–60.
Li QL, Chen TJ, Wang YL, Bryant SH. Pubchem as a public resource for drug discovery. Drug Discov. 2010;15:1052–7.
Rotmensch M, Halpern Y, Tlimat A, Horng S, Sontag D. Learning a health knowledge graph from electronic medical records. Sci Rep. 2017;7:1–7.
Himmelstein DS, Baranzini SE. Heterogeneous network edge prediction: a data integration approach to prioritize disease-associated genes. PLoS Comput Biol. 2015;11:1004259.
Yu Y, Huang KX, Zhang C, Glass LM, Sun JM, Xiao C. SumGNN: multi-typed drug interaction prediction via efficient knowledge graph summarization. Bioinformatics. 2021;37:2988–95.
Wang, X., Wang, R., Shi, C., Song, G., Li, Q.. Multi-component graph convolutional collaborative filtering, In: Proceedings of 34th AAAI Conference on Artificial Intelligence, 6267–6274 (2020)
Hu J, Shen L, Albanie S, Sun G, Wu E. Squeeze-andexcitation networks. IEEE Trans Pattern Anal Mach Intell. 2020;42:2011–23.
Dong, Y., Seltzer, M. L.. Improved bottleneck features using pretrained deep neural networks, in: INTERSPEECH 2011, 12th Annual Conference of the International Speech Communication Association, 244–247 (2011)
Acknowledgements
The work reported in this paper was partially supported by the National Natural Science Foundation of China project 61963004.
Funding
The funding received from National Natural Science Foundation of China, 61963004, Qingfeng Chen.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors of this manuscript have directly participated in planning, execution, and/or analysis of this study. And we declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, L., Chen, Q. & Lan, W. Predicting drug–drug interactions based on multi-view and multichannel attention deep learning. Health Inf Sci Syst 11, 50 (2023). https://doi.org/10.1007/s13755-023-00250-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13755-023-00250-x